• Quick note - the problem with Youtube videos not embedding on the forum appears to have been fixed, thanks to ZiprHead. If you do still see problems let me know.

Biotech industry set for big changes

jay gw

Unregistered
Joined
Sep 11, 2004
Messages
1,821
A small non-profit biotech research organisation in Australia is set to change the biotech industry. CAMBIA has found a new way of transferring genetic material to plants.

It bypasses the heavily-patented agrobacterium transformation (AT) method. Researchers have placed this tool in the public sphere by distributing it under an open source licence called Biological Initiative for Open Source (BIOS).

Any researcher or company can use the technology but is legally obliged to make new discoveries based on its use available to others. The patent-driven monopolistic biotech must rethink its business strategies.

Sharing information is hardly a standard practice in biotech industry. Richard Jefferson, head of CAMBIA, says the plethora of patents surrounding the AT method made it difficult for researchers to develop countries to experiment in key areas such as agriculture.

The developing world could only rely on products major patent holders sold. Sharing information, Jefferson says, empowers scientists across the world to create products more suitable for their societies. This is the basis of the BIOS initiative.

http://www.thestatesman.net/page.news.php?clid=24&theme=&usrsess=1&id=74551
 
I must say I'm a bit unsure about this development. Developing pharmaceuticals is a very risky and costly enterprise for any one, even small and smart biotech companies. If the companies can’t make enough money someone else has to step in to pay for the research. Who, the government?

On the other hand, all big pharma today, make loads of money, and not that much go back into the company. So an open source approach could give big pharma a much needed kick in the butt! And also make it possible for small and smart enterprises to make something worthwhile without go to extremes to raise funds.

Anyways, with BIOS, we might be standing before a paradigm shift in the biotech business, just as the software industry of today is facing.

[edit: Hey I just turned 666 now, that calls for a cold beer ;) }
 

Back
Top Bottom